Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting?

Annals of Thoracic and Cardiovascular Surgery

Volumn 17, Issue 4, 2011, Pages 376-382

  Sakamoto, Hiroaki ^a   Watanabe, Yasunori ^a   Satou, Masataka ^a  

^a Hitachi   (Japan)

Author keywords

Atrial fibrillation; Coronary artery bypass grafting; Statin

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AGED; ANALYSIS OF VARIANCE; ARTICLE; CHI SQUARE DISTRIBUTION; CORONARY ARTERY BYPASS GRAFT; DRUG ADMINISTRATION; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; JAPAN; MALE; MIDDLE AGED; RETROSPECTIVE STUDY; RISK; RISK ASSESSMENT; RISK FACTOR; TIME; TREATMENT OUTCOME;

AGED; ANALYSIS OF VARIANCE; ATRIAL FIBRILLATION; CHI-SQUARE DISTRIBUTION; CORONARY ARTERY BYPASS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; JAPAN; MALE; MIDDLE AGED; ODDS RATIO; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 80052163711     PISSN: 13411098     EISSN: None     Source Type: Journal    
DOI: 10.5761/atcs.oa.10.01588     Document Type: Article

References (19)

1. Aranki SF, Shaw DP, Adams DH, Rizzo RJ, Couper GS, et al. Predictors of atrial fibrillation after coronary artery surgery. Current trends and impact on hospital resources. Circulation 1996; 94: 390-397.
2. Zaman AG, Archbold RA, Helft G, Paul EA, Curzen N P, et al. Atrial fibrillation after coronary artery bypass surgery: a model for preoperative risk stratification. Circulation 2000; 101: 1403-1408.
3. Mathew JP, Fontes ML, Tudor IC, Ramsay J, Duke P, et al. Multicenter Study of Perioperative Ischemia Research Group. A multicenter risk index for atrial fibrillation after cardiac surgery. JAMA 2004; 291: 1720-1729.
4. Nissen SE, Tuzcu EM, Schoenhagen P, Crowe T, Sasiela WJ, et al. Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease. N Engl J Med 2005; 352: 29-38.
5. Schoenhagen P, Tuzcu EM, Apperson-Hansen C, Wang C, Wolski K, et al. Determinants of arterial wall remodeling during lipid-lowering therapy: serial intra-vascular ultrasound observations from the Reversal of Atherosclerosis with Aggressive Lipid Lowering Therapy (REVERSAL) trial. Circulation 2006; 113: 2826-2834.
6. Thielmann M, Neuhauser M, Marr A, Jaeger BR, Wendt D, et al. Lipid-lowering effect of preoperative statin therapy on postoperative major adverse cardiac events after coronary artery bypass surgery. J Thorac Cardiovasc Surg 2007; 134: 1143-1149.
7. Lazar HL, Bao Y, Zhang Y, Bernard SA. Pretreatment with statins enhances myocardial protection during coronary revascularization. J Thorac Cardiovasc Surg 2003; 125: 1037-1042.
8. Mannacio VA, Iorio D, De Amicis V, Di Lello F, Musumeci F. Effect of rosuvastatin pretreatment on myocardial damage after coronary surgery: a randomized trial. J Thorac Cardiovasc Surg 2008; 136: 1541-1548.
9. Miceli A, Fino C, Fiorani B, Yeatman M, Narayan P, et al. Effects of preoperative statin treatment on the incidence of postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting. Ann Tho-rac Surg 2009; 87: 1853-1858.
10. Hernandez F, Cohn WE, Baribeau YR, Tryzelaar JF, Charlesworth DC, et al. In-hospital outcomes of off-pump versus on-pump coronary artery bypass procedures: a multicenter experience. Ann Thorac Surg 2001; 72: 1528-1533.
11. Patti G, Chello M, Candura D, Pasceri V, D'Ambrosio A, et al. Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Ator-vastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) study. Circulation 2006; 114: 1455-1461.
12. Mariscalco G, Lorusso R, Klersy C, Ferrarese S, Tozzi M, et al. Observational study on the beneficial effect of preoperative statins in reducing atrial fibrillation after coronary surgery. Ann Thorac Surg 2007; 84: 1158-1164.
13. Lertsburapa K, White CM, Kluger J, Faheem O, Hammond J, et al. Preoperative statins for the prevention of atrial fibrillation after cardiothoracic surgery. J Thorac Cardiovasc Surg 2008; 135: 405-411.
14. Burgess DC, Kilborn MJ, Keech AC. Interventions for prevention of post-operative atrial fibrillation and its complications after cardiac surgery: a meta-analysis. Eur Heart J 2006; 27: 2846-2857.
15. Ali IM, Sanalla AA, Clark V. Beta-blocker effects on postoperative atrial fibrillation. Eur J Cardiothorac Surg 1997; 11: 1154-1157.
16. Banach M, Rysz J, Drozdz JA, Okonski P, Misztal M, et al. Risk factors of atrial fibrillation following coronary artery bypass grafting: a preliminary report. Circ J 2006; 70: 438-441.
17. Hu S, Zheng Z, Yuan X, Wang W, Song Y, et al. Increasing long-term major vascular events and resource consumption in patients receiving off-pump coronary artery bypass. A single-center prospective observational study. Circulation 2010; 121: 1800-1808.
18. Ishida M, Kobayashi J, Tagusari O, Bando K, Niwaya K, et al. Perioperative advantages of off-pump coronary artery bypass grafting. Circ J 2002; 66: 795-799.
19. Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008; 359: 2195-2207.